Medical Devices Today

Deals Update

Article preview reprinted Medtech Insight - September 2008

Find out about recent medtech strategic alliances, mergers & acquisitions and financings.

Device VCs not Immune to Crisis

Article preview reprinted from Start-Up - October 2008

Find out how the difficulties on Wall Street are washing down to the private market causing medical device VCs to reconsider investment strategies and exiting routes.

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2008

Article preview reprinted from IN VIVO - October 2008

Highlights from the Q2 2008 review of device and diagnostics dealmaking: financing for medical device firms was down 9% from the first quarter to $838mm, which consisted mainly of late-stage venture rounds at 43% of the total.

FDA Lifts Boston Scientific Warning Letter Restrictions On PMA Approvals

Full article reprinted from "The Gray Sheet" - October 27, 2008

Boston Scientific anticipates FDA approval of its Express SD renal stent, among other products, now that the agency has lifted the restrictions on Class III device approvals imposed by a 2006 company-wide warning letter.

LabCorp Pulls OvaSure, But Charges FDA With Overreaching

Full article reprinted from "The Gray Sheet" - October 27, 2008

Laboratory Corporation of America pulled its early-stage ovarian cancer test service from the market last week in response to FDA scrutiny, but the lab giant called the agency's actions leading up to the withdrawal "unprecedented."

Guidelines Proposed For Live-Case Demonstrations

Full article reprinted from "The Gray Sheet" - October 27, 2008

Prominent interventional cardiologists plan to create guidelines for live case demonstrations that are broadcast at professional meetings in the face of intensifying scrutiny on the practice.

BPH: An Expanding Opportunity

Article preview reprinted Medtech Insight - September 2008

Find out how directed energy device-based medical therapies have greatly influenced the way physicians deliver care in a number of medical specialties.

European Markets for Benign Prostatic Hyperplasia Therapies

Article preview reprinted from Start-Up - September 2008

Investor interest in the urology space waxes and wanes; it's attractive because as a niche specialty it has some pretty big patient populations. Benign prostatic hyperplasia (BPH), the benign enlargement of the prostate over time, affects 90% of men by the time they're 80, and half of men at age 60.

Amedica Takes On Tough Sell in Orthopedics

Article preview reprinted from IN VIVO - September 2008

Amedica says its high-strength silicon nitride-based ceramic could be the answer to some of the more vexing problems in spine, hip and knee surgeries. But can this materials science expert become a real orthopedics company?

FDA Previews Final Drug-Eluting Stent Guidance

Full article reprinted from "The Gray Sheet" - October 20, 2008

FDA previewed several changes it will make in its final drug-eluting stent guidance at the Transcatheter Cardiovascular Therapeutics symposium in Washington, D.C., on Oct. 15.